IRIS
MARZIO, Leonardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.056
EU - Europa 4.699
AS - Asia 2.704
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 6
AF - Africa 5
SA - Sud America 5
Totale 12.492
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.029
CN - Cina 1.061
UA - Ucraina 965
IE - Irlanda 765
IT - Italia 688
TR - Turchia 680
SE - Svezia 626
SG - Singapore 530
GB - Regno Unito 526
FR - Francia 418
IN - India 371
DE - Germania 279
FI - Finlandia 183
RU - Federazione Russa 131
PL - Polonia 37
VN - Vietnam 34
CA - Canada 18
BE - Belgio 17
EU - Europa 17
RO - Romania 14
CZ - Repubblica Ceca 10
GR - Grecia 10
MX - Messico 9
IL - Israele 7
AU - Australia 6
IR - Iran 5
AL - Albania 4
ES - Italia 4
HK - Hong Kong 4
KR - Corea 4
NL - Olanda 4
PT - Portogallo 4
AT - Austria 3
CL - Cile 3
EG - Egitto 3
LT - Lituania 3
NO - Norvegia 3
TW - Taiwan 3
CH - Svizzera 2
CO - Colombia 2
PK - Pakistan 2
SC - Seychelles 2
DK - Danimarca 1
GE - Georgia 1
ID - Indonesia 1
KH - Cambogia 1
LU - Lussemburgo 1
MD - Moldavia 1
Totale 12.492
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.078
Chandler 779
Dublin 753
Dearborn 458
Singapore 443
Southend 422
Princeton 386
Izmir 333
Nanjing 327
Wilmington 257
Cambridge 181
Beijing 157
Woodbridge 118
Ann Arbor 113
Ashburn 109
Nanchang 104
Santa Clara 94
Boardman 65
Shenyang 62
Houston 61
New York 60
Hebei 56
Altamura 54
Kunming 49
Tianjin 46
Jiaxing 44
Rome 40
Kraków 36
Chieti 35
Los Angeles 33
Hangzhou 31
Jinan 26
Bologna 25
Norwalk 24
Grevenbroich 22
Hefei 22
Dong Ket 20
Orange 20
Changsha 19
Guangzhou 19
Brussels 16
Washington 16
Düsseldorf 15
Milan 15
Vinh 14
Augusta 13
Changchun 12
Lanzhou 12
Pescara 11
San Mateo 11
Ningbo 10
Cepagatti 9
Fuzhou 9
Guadalajara 9
Moscow 9
Brno 8
L'aquila 8
Bellante 7
Helsinki 7
Seattle 7
Toronto 7
Zhengzhou 7
Kocaeli 6
Tappahannock 6
Varallo 6
Auburn Hills 5
Edinburgh 5
Leawood 5
Munich 5
Siena 5
Taizhou 5
Turin 5
Villamagna 5
Cedar Knolls 4
Frankfurt am Main 4
Hong Kong 4
Isernia 4
Melbourne 4
Palermo 4
Pompei 4
Redwood City 4
Sulmona 4
Walnut 4
Xian 4
Avezzano 3
Baotou 3
Cairo 3
Castelfranco di Sotto 3
Falls Church 3
Haikou 3
Limeil-brévannes 3
London 3
Mountain View 3
Ottawa 3
Romola 3
San Vito al Tagliamento 3
Simi Valley 3
Torrevecchia Teatina 3
Verona 3
Villafranca di Verona 3
Totale 7.363
Salva come PNG Salva come JPEG
Nome #
Il tempo di transito oro-cecale (TTOC) è accelerato dopo somministrazione orale di allergene alimentare nei pazienti con sindrome del colon irritabile (SCI) e prick test positivo 357
EFFICACY OF TREATMENT WITH PYLERA IN COMBINATION WITH RANITIDINE ON FIRST-LINE INFECTION HELICOBACTER PYLORI: EXPERIENCE OF A SINGLE CENTER 142
SYMPTOM PATTERN IN FUNCTIONAL DYSPEPSIA AND GASTROESOPHAGEAL REFLUX DISEASE: ROLE OF H. PYLORI INFECTION 116
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy 110
A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study 110
SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis 110
Trasmissione di Helicobacter pylori in un modello murino 108
24-hour pancolonic motility using a portable electronic probe in healthy subjects 104
48-Hour continuous pH measurement in patients with gastro-oesophageal reflux: effect of cisapride. 104
Helicobacter pylori isolates from proximal and distal stomach of patients never treated and already treated show genetic variability and discordant antibiotic resistance. 102
Antibacterial effect of plant extracts against Helicobacter pylori 101
Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study. 99
Detection of Helicobacter pylori in the gastrointestinal tract of Balb/C euthymic mice infected by human Helicobacter pylori and evidence for transmission 98
Heightened free radical activity in angina pectoris 97
Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy. 95
Treatment of Helicobacter pylori (Hp) infection with an association of Omeprazole and Roxytromicine: a study in vivo and in vitro. 94
FUSOBACTERIUM NUCLEATUM (FN) IN PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE 94
Correlation between anal canal size and anal canal pressure: an ultrasonografhip and manometric study 93
L'eritromicina accelera lo svuotamento gastrico e colecistico nell'uomo attraverso un meccanismo mediato dall'acetilcolina 93
Two weeks regimen with amoxillicin, tinidazole and omeprazole eradicates helicobacter pylori and cures active duodenal ulcer 92
Uso razionale di schemi terapeutici nelle infezioni da Helicobacter pylori 92
Anti-H pylori specific antibody immunoistochemistry improves the diagnostic accuracy of H piylori in biopsy specimen from patients treated with triple therapy 90
Circadian variations in antioxidant defences and lipid peroxidation in the rat heart 90
Morphological and motor changes during experimental colits in rats are prevented by a specific substance p antagonist 90
ESOPHAGITIS AND ITS CAUSES: WHO IS "GUILTY" WHEN ACID IS FOUND "NOT GUILTY"? 89
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD). 88
Triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacte pylori infection. A double blind placebo controlled trial. 87
Beneficial effects of SR140333, a novel substance P antagonist, in a rat model of experimental colitis 86
Diameters and pressures of the anal canal simultaneously measured with endosonography and manometry 85
Effects of combining extracts (from Propolis or Zingiber officinale) with Clarithromycin on H.pylori. 85
Coccoid Helicobacter pylori not culturable in vitro reverts in mice. 85
Detection of Helicobacter pylori in saliva and esophagus 85
Anal canal diameters and pessure measured simultaneously by real time ultrasonography and manometry in human subjects 83
Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy.Am. J. Gastroenterol 83
MIGRATING MOTOR COMPLEX RECORDED SPONTANEOUSLY AND INDUCED BY MOTILIN AND ERYTHROMYCIN IN AN EX VIVO RABBIT INTESTINAL PREPARATION 83
Masse all'ipocondrio dx e carcinoma della colecisti 83
Cigarette smoke, ferritin, and lipid peroxidation 83
Detection of Helicobacter pylori in esophagus and saliva in humans 81
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD) 81
COMBINED VIDEOCAPSULE ENDOSCOPY (VCE) AND LACTULOSE HYDROGEN BREATH TEST (LHBT): A COMPARATIVE STUDY TO ASSESS ORO-CECAL TRANSIT TIME (OCTT). 81
Alterazioni contrattili della muscolatura liscia nel corso di colite sperimentale sono ridotte da un antagonista specifico della sostanza P 81
Short- and long-term omeplazole for the tratment and prevention of duodenal ulcer, and effect on helicobacter pylori 80
Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. 80
Swallows, oesophageal and gastric motility in normal subjects and in patients with gastro-oesophageal reflux disease: a 24-h-pH-manometric study 79
Effect of glyceryl trinitrate ointment (GTO) 0.2% and 2% on anal canal pressure during acute and chronic application in patients with anal fissure 79
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC) 79
Effects of cimetropium bromide on gallbladder contraction in response to oral and intraduodenal olive oil. 79
Blood cardioplegia reduces oxidant burden in the ischemic and reperfused human myocardium 79
Esophageal and gastric motility in patients with gastroesophageal reflux disease 78
GRAVIDANZA IN UNA PAZIENTE AFFETTA DA RETTOCOLITE ULCEROSA IN TERAPIA CON INFLIXIMAB: CASO CLINICO 78
H2-RECEPTOR ANTAGONISTS ARE SCAVENGERS OF OXYGEN RADICALS 78
SHORT AND LONG TERM EFFICACY OF GLYCERYL TRINITRATE (GTN) OINTMENT 0.2% AND 2% ON ANAL CANAL PRESSURE IN PATIENTS WITH CHRONIC ANAL FISSURES. 78
EFFECT OF CLEBOPRIDE ON ESOPHAGEAL MOTOR FUNCTION IN GERD PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY: EVALUATION USING HIGH RESOLUTION MANOMETRY 78
PRUCALOPRIDE ACCELERATES GASTRIC AND SMALL BOWEL TRANSIT TIMES OF VIDEOCAPSULES ENDOSCOPY 78
Heparin: does it act as an antioxidant in vivo? 77
TRANSIENT LOWER ESOPHAGEAL SPHINCTER RELAXATIONS AND GASTRO-ESOPHAGEAL REFLUX EPISODES IN HEALTHY SUBJECTS AND GERD PATIENTS DURING 24 HOURS 77
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC). 77
Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. 76
EFFECT OF THE 5-HT3 RECEPTOR ANTAGONIST, ONDANSETRON, ON GASTRIC SIZE IN DYSPEPTIC PATIENTS WITH IMPAIRED GASTRIC ACCOMODATION 76
TYPICAL AND ATYPICAL SYMPTOMS OF GASTRO ESOPHAGEAL REFLUX DISEASE: DOES Helicobacter pylori MATTER? 76
null 76
Gastric antral and fundus receptive relaxation in dyspeptic patients and normal subjects 75
Evidence for an oro-fecal transmission inan experimental murine model of helicobacter pylori infection. 75
Rifabutin based triple therapy for eradication of H.pylori primary and secondary resistant to tinidazole and clarithromycin 75
Identification of a novel mutation affecting domain V of the 23S rRNA gene in Helicobacter pylori 75
LA MALDIGESTIONE 75
5-HT1-RECEPTOR AGONIST SUMATRIPTAN MODIFIES GASTRIC SIZE AFTER 500 ML OF WATER IN DYSPEPTIC PATIENTS AND NORMAL SUBJECTS 74
Role of U.S. and oral colecistography in pre-operative diagnostic approach to cholelithiasis 74
Effect of omeprazole, clarithromicin and amoxicillin for a short time on helicobacter pylori eradication 73
ESOPHAGEAL MOTILITY ASSESSMENT AFTER PRUCALOPRIDE ADMINISTRATION IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY (IEM) AND SYSTEMIC SCLEROSIS. 73
Pharyngeal, Esophageal and Gastric Motility in Normal Subjects and in patients with gastroesophageal Reflux Disease 72
Regional distribution of glutathione-related antioxidant defences in the normal rabbit aorta. 72
Erythromycin accellerates gastric and gallbladder emptying through a cholinergic mediated mechanism in humans 72
Proximal and Distal Gastric Distension in Normal Subjects and H.pylori-Positive and -Negative Dyspeptic Patients and Correlation with Symptoms 71
EFFECT OF HYOSCINE N-BUTYLBROMIDE ON GASTROESOPHAGEAL REFLUX IN NORMAL SUBJECTS AND PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE. 71
Oesophageal and gastric motility in patients with gastro-oesophageal reflux disease 70
Distensione gastrica nei soggetti normali e nei pazienti dispeptici helicobacter pylori positivi e negativi e correlazione con i sintomi 70
Role of transient lower esophageal sphincter relaxations in the genesis of priximal gastro-esophageal reflux 70
La terapia chirurgica laparoscopica della malattia da reflusso gastro-esofageo 70
EFFICACIA E SICUREZZA DEL RITRATTAMENTO CON INFLIXIMAB IN UN PAZIENTE AFFETTO DA MORBO DI CROHN 70
Influence of physical activity on gastric emptying of liquids in normal human subjects 70
EFFECT OF AN ACUTE INTRALUMINAL ADMINISTRATION OF CAPSAICIN ON OESOPHAGEAL MOTOR PATTERN IN GORD PATIENTS WITH INEFFECTIVE OESOPHAGAL MOTILITY 70
Aortic glutathione-related antioxidant defences in rabbits subjected to suprarenal aortic coarctation hypertension 70
SPONTANEOUS OPENING OF LES IN ACHALASIA: AN UNCOMMON ON-LINE DOCUMENTATION BY HIGH-RESOLUTION MANOMETRY 70
I RILASCIAMENTI TRANSITORI DELLO SFINTERE ESOFAGEO INFERIORE NELLA GENESI DEI REFLUSSI GASTRO-ESOFAGEI: PROSPETTIVE TERAPEUTICHE 69
DISORDINI MOTORI ASPECIFICI DELL’ESOFAGO 69
Gastric antral and fundic distention evaluated by ultrasonography (US) in normal subjects and patients with idiopathic dyspepsia 68
EFFECT OF CIMETROPIUM BROMIDE ON GALLBLADDER CONTRACTION IN RESPONSE TO ORAL AND INTRADUODENAL OLIVE OIL 68
EFFECT OF THE 5-HT1 AGONIST SUMATRIPTAN ON ESOPHAGEAL MOTOR PATTERN IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY 68
CAN HELICOBACTER PYLORI INFECTION HAVE A ROLE ON CLINICAL APPEARANCE OF GERD? 68
EVALUATION OF LIVER BLOOD FLOW AND FIBROSIS IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CIRRHOSIS IN COMPARISON WITH NORMAL CONTROLS THROUGH CONTRAST ENHANCED ULTRASOUND(CEUS) AND FIBROSCAN 68
Mouth to caecum transit time (MCTT) is accellerated after oral food antigen in patients with irritable bowel syndrome 68
GASTRIC AND GALLBLADDER EMPTYING AFTER STANDARD SOLID MEAL IN NORMAL CONTROLS, PATIENTS WITH “MOTILITY-LIKE” DYSPEPSIA AND EFFECT OF DOMPERIDONE. 67
EVALUATION OF FIBROSIS AND INTRAPARENCHIMAL BLOOD FLOW INCHIRROTIC PATIENTS, CHRONIC ACTIVE HEPATITIS AND NORMAL CONTROLS THROUGH FIBROSCAN AND ULTRASOUND ENHANCED CONTRAST MEDIA. 67
Changes in the myocardial enzymatic systems (AES) induced by ischemia-reperfusion in the isolated rat heart 67
THE VALUE OF CONTRAST ENHANCED ENDOSCOPIC ULTRASOUND IN THE FINE NEEDLE ASPIRATION 67
Prolonged anal sphincter manometry in normal human subjects 66
ROLE OF PRUCALOPRIDE (RESOLOR) IN THE SETTING-UP OF PILLCAM COLON-CAPSULE ENDOSCOPY (CCE). EXPERIENCEFROM A SINGLE CENTRE 66
EVALUATION OF INTRA PARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND FIBROSIS BY FIBROSCAN IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON ALCOHOLIC STEATOHEPATITIS (NASH) AND COMPARISON WITH NORMAL CONTROLS 66
Registrazione delle 24 ore della motilità del piloro in soggetti normali 65
Totale 8.402
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.418
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.418
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.598 0 0 0 0 215 333 380 285 37 124 224 0
2020/20211.118 187 5 188 10 87 239 14 18 80 190 23 77
2021/2022794 28 12 6 200 75 9 10 65 55 6 89 239
2022/20232.220 199 234 122 268 186 514 150 160 259 29 54 45
2023/20241.019 77 52 65 29 33 313 252 40 3 41 17 97
2024/2025998 189 410 308 38 53 0 0 0 0 0 0 0
Totale 12.750